I have the same question, too.This stock has been such a mess for so long that nobody knows what is around the corner. For holders, it has been a huge disappointment. One thing for sure is that it is not loved.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%